Predictors of early relapse in patients with non-infectious mixed cryoglobulinemia vasculitis: results from the French nationwide CryoVas survey.

Abstract:

OBJECTIVE:Although in most patients induction therapy leads to complete or partial remission, relapses in patients with non-infectious mixed cryoglobulinemia vasculitis (CryoVas) remain a major problem. We aimed to identify predictors of early relapses occurring within the first 12months of treatment in such patients. METHODS:Patients included in the French CryoVas survey exhibiting complete/partial clinical remission and followed-up for at least 12months after induction therapy (n=145) were analyzed for predictors of early relapses. RESULTS:Forty out of 145 patients (28%) experienced early relapse. Relapses occurred after a median time of 9.5months after induction therapy (3-12) and involved skin (75%), joints and peripheral nerve (28% each), kidneys (25%) and gastrointestinal tract (5%). Baseline factors associated with an early relapse were purpura [HR 3.35 (1.02-10.97), P=0.046], cutaneous necrosis [HR 4.46 (1.58-12.57), P=0.005] and articular involvement [HR 2.20 (1.00-4.78), P=0.048]. The only factor negatively associated with an early relapse during follow-up was the achievement of complete immunological response [HR 0.07 (0.01-0.51), P=0.009]. The use of corticosteroids plus rituximab or cyclophosphamide tended to be associated negatively with early relapse [HR 0.43 (0.17-1.08), P=0.07]. CONCLUSION:In patients with non-infectious CryoVas, main predictors of early relapses after initial remission are purpura, articular involvement, and cutaneous necrosis. The absence of complete immunological response during follow-up was associated with early relapse. These findings may help in adapting future treatment strategies.

journal_name

Autoimmun Rev

journal_title

Autoimmunity reviews

authors

Terrier B,Marie I,Launay D,Lacraz A,Belenotti P,de Saint-Martin L,Quemeneur T,Huart A,Bonnet F,Le Guenno G,Kahn JE,Hinschberger O,Rullier P,Diot E,Lazaro E,Bridoux F,Zénone T,Carrat F,Hermine O,Léger JM,Mariette X

doi

10.1016/j.autrev.2013.11.006

subject

Has Abstract

pub_date

2014-06-01 00:00:00

pages

630-4

issue

6

eissn

1568-9972

issn

1873-0183

pii

S1568-9972(14)00007-X

journal_volume

13

pub_type

杂志文章,评审
  • Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseases.

    abstract::Mesenchymal stem cells (MSCs) are non-hematopoietic, multipotent progenitor cells which can be isolated from various human adult tissues. In recent years, MSCs have been shown to possess broad immunoregulatory capabilities, modulating both adaptive and innate immunity. This review discusses the documented immunomodula...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.01.005

    authors: Ben-Ami E,Berrih-Aknin S,Miller A

    更新日期:2011-05-01 00:00:00

  • Antiphospholipid antibodies and the risk of thrombocytopenia in patients with systemic lupus erythematosus: A systematic review and meta-analysis.

    abstract:BACKGROUND:According to criteria for the classification of Systemic Lupus Erythematosus (SLE), thrombocytopenia is one of the disease-defining hematologic disorders. Since the recognition of Antiphospholipid Syndrome (APS), thrombocytopenia was frequently reported but several studies yielded contradictory results on th...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,meta分析

    doi:10.1016/j.autrev.2019.102395

    authors: Chock YP,Moulinet T,Dufrost V,Erkan D,Wahl D,Zuily S

    更新日期:2019-11-01 00:00:00

  • Behçet's syndrome patients exhibit specific microbiome signature.

    abstract:BACKGROUND AND AIMS:Behçet syndrome is a systemic inflammatory condition characterized by muco-cutaneous and ocular manifestations, with central nervous system, vascular and/or gastro-intestinal involvement. The association of microbiota with Behçet syndrome has not been shown yet. Our work was aimed to compare the gut...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2014.11.009

    authors: Consolandi C,Turroni S,Emmi G,Severgnini M,Fiori J,Peano C,Biagi E,Grassi A,Rampelli S,Silvestri E,Centanni M,Cianchi F,Gotti R,Emmi L,Brigidi P,Bizzaro N,De Bellis G,Prisco D,Candela M,D'Elios MM

    更新日期:2015-04-01 00:00:00

  • Modulation of autoimmunity with artificial peptides.

    abstract::The loss of immune tolerance to self antigens leads to the development of autoimmune responses. Since self antigens are often multiple and/or their sequences may be known, one approach to restore immune tolerance uses synthetic artificial peptides that interfere or compete with self peptides in the networks of cellula...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2010.08.017

    authors: La Cava A

    更新日期:2010-11-01 00:00:00

  • Vitamin D: the alternative hypothesis.

    abstract::Early studies on vitamin D showed promise that various forms of the "vitamin" may be protective against chronic disease, yet systematic reviews and longer-term studies have failed to confirm these findings. A number of studies have suggested that patients with autoimmune diagnoses are deficient in 25-hydroxyvitamin D ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2009.02.011

    authors: Albert PJ,Proal AD,Marshall TG

    更新日期:2009-07-01 00:00:00

  • Modulation of endothelial cell damages by anti-Hsp60 autoantibodies in systemic autoimmune diseases.

    abstract::Heat-shock protein (Hsp) family is made up of heterogeneous proteins of which Hsp60 members are the most studied. It is now generally admitted that Hsp60 is not only a mitochondrial component but can be localized on the membrane cell surface. Considered as a signal danger following infections, Hsp60 can induce the pro...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2007.01.012

    authors: Alard JE,Dueymes M,Youinou P,Jamin C

    更新日期:2007-08-01 00:00:00

  • Anti-neutrophil cytoplasmic autoantibodies: methodological aspects and clinical significance in systemic vasculitis.

    abstract::Antineutrophil cytoplasmic antibodies (ANCA) are the serological hallmark of some idiopathic systemic vasculitides, such as granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and, to a lesser extent, Churg-Strauss syndrome (CCS), the so-called ANCA-associated vasculitides (AAV). ANCA were first det...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2012.08.008

    authors: Radice A,Bianchi L,Sinico RA

    更新日期:2013-02-01 00:00:00

  • Ocular involvement in granulomatosis with polyangiitis: A single-center cohort study on 63 patients.

    abstract:OBJECTIVE:To analyse the ocular manifestations of patients with GPA, their treatment and outcome. METHODS:Retrospective cohort study performed at the National Referral Center for Vasculitis, Cochin Hospital, Paris (France), from January 2005 to December 2015. Among 308 patients with a new diagnosis of GPA in accordanc...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2019.03.001

    authors: Pérez-Jacoiste Asín MA,Charles P,Rothschild PR,Terrier B,Brézin A,Mouthon L,Guillevin L,Puéchal X

    更新日期:2019-05-01 00:00:00

  • CTLA-4 and autoimmunity: new insights into the dual regulator of tolerance.

    abstract::Cytotoxic T-Lymphocye Antigen 4 (CTLA-4) or CD152 is an inhibitory molecule that plays a critical role in maintenance of tolerance to self-antigens. CTLA-4 is structurally as well as functionally related to CD28, since it shares 31% of homology and binds the B7 family molecules CD80 and CD86 with higher affinity. Neve...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2013.07.002

    authors: Romo-Tena J,Gómez-Martín D,Alcocer-Varela J

    更新日期:2013-10-01 00:00:00

  • CD20: a target antigen for immunotherapy of autoimmune diseases.

    abstract::This article reviews the role of CD20 antigen in B cell function and the effectiveness and limits of passive immunotherapy with anti-CD20 monoclonal antibody (Rituximab) in the treatment of autoimmune (or immune-mediated) diseases. Active immunotherapy is a more feasible way to control these chronic diseases. A peptid...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2005.04.004

    authors: Perosa F,Favoino E,Caragnano MA,Prete M,Dammacco F

    更新日期:2005-11-01 00:00:00

  • X chromosome monosomy in primary and overlapping autoimmune diseases.

    abstract::Female predominance is a common characteristic for autoimmune diseases attributed to the combined effect of hormonal influence and genetic factors. Since X chromosome has immunologically important genes, the age related X chromosome loss could contribute to the development of autoimmunity. X chromosome monosomy (XCM) ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2010.03.001

    authors: Svyryd Y,Hernández-Molina G,Vargas F,Sánchez-Guerrero J,Segovia DA,Mutchinick OM

    更新日期:2012-03-01 00:00:00

  • Importance of the dense fine speckled pattern on HEp-2 cells and anti-DFS70 antibodies for the diagnosis of systemic autoimmune diseases.

    abstract::The presence of anti-nuclear antibodies (ANA) is a hallmark of systemic autoimmune rheumatic diseases (SARD). The indirect immunofluorescence (IIF) assay on HEp-2 cells is a commonly used test for the detection of ANA and was recently recommended as the screening test of choice by a task force of the American College ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.11.005

    authors: Mahler M,Hanly JG,Fritzler MJ

    更新日期:2012-07-01 00:00:00

  • The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk.

    abstract::Rheumatoid arthritis (RA) patients have an incidence of cardiovascular (CV) diseases at least two times higher than the general population. Atherosclerosis, the main determinant of CV morbidity and mortality, and carotid intima-media thickness, an early preclinical marker of atherosclerosis, also occur early on in RA....

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.04.018

    authors: Gremese E,Ferraccioli G

    更新日期:2011-08-01 00:00:00

  • Clinical characteristics and risk factors for low dose methotrexate toxicity: a cohort of 28 patients.

    abstract:OBJECTIVE:Low dose (10-25 mg/week) methotrexate is widely used for the management of systemic inflammatory diseases, and is considered to be relatively safe. Toxicity due to low dose MTX has been reported but is poorly characterized. We describe the clinical features, risk factors, and outcomes of low dose MTX toxicity...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2014.08.027

    authors: Kivity S,Zafrir Y,Loebstein R,Pauzner R,Mouallem M,Mayan H

    更新日期:2014-11-01 00:00:00

  • Bisphosphonates in patients with autoimmune rheumatic diseases: Can they be used in women of childbearing age?

    abstract::Autoimmune rheumatic diseases (ARD) are prevalent in women during their childbearing age. For their treatment, high doses of corticosteroid (CS) for long-term periods are often required, increasing the risk of bone loss. According to recent guidelines, bisphosphonates (BP) should be used as first line treatment to pre...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2010.03.002

    authors: Losada I,Sartori L,Di Gianantonio E,Zen M,Clementi M,Doria A

    更新日期:2010-06-01 00:00:00

  • New insights into the pathogenesis of Behçet's disease.

    abstract::Behçet's disease (BD) is a recurrent systemic inflammatory disorder of unknown origin characterized by oral and genital mucous ulcer, uveitis, and skin lesions. Involvement of large vessels, central nervous system (CNS), gastrointestinal tract and thrombotic events are less frequent but can be life threatening. The ai...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.11.026

    authors: Pineton de Chambrun M,Wechsler B,Geri G,Cacoub P,Saadoun D

    更新日期:2012-08-01 00:00:00

  • Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis: A systematic literature review.

    abstract:OBJECTIVE:We investigated the effectiveness of rituximab (an anti-CD20 monoclonal antibody) in patients with eosinophilic granulomatosis with polyangiitis (EGPA). METHODS:We performed a systematic literature review from the inception dates until July 20, 2020 for articles reporting rituximab administration to treat EG...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2020.102737

    authors: Akiyama M,Kaneko Y,Takeuchi T

    更新日期:2021-02-01 00:00:00

  • Churg-Strauss Syndrome: an evolving paradigm.

    abstract::The Churg-Strauss Syndrome is an ANCA-associated vasculitis, an inflammatory multisystem disease with preference to the respiratory tract. Peripheral and tissue eosinophilia are the pathological hallmarks of this condition. The etiopathogenesis is unknown but some cytokines appear to play a central role and could be t...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2012.07.009

    authors: Ramentol-Sintas M,Martínez-Valle F,Solans-Laqué R

    更新日期:2012-12-01 00:00:00

  • Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases.

    abstract:OBJECTIVE:To describe the clinical and immunologic features of 6 patients with rheumatic disease and Hepatitis C Virus (HCV) chronic infection, treated with anti-TNF alpha drugs. PATIENTS AND METHODS:Six patients, with repeated positive serology for HCV infection, were affected by Rheumatoid arthritis (RA) (4 cases), ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2008.05.002

    authors: Cavazzana I,Ceribelli A,Cattaneo R,Franceschini F

    更新日期:2008-12-01 00:00:00

  • Toll-like receptor 4 gene polymorphism and giant cell arteritis susceptibility: a cumulative meta-analysis.

    abstract:OBJECTIVE:Toll-like receptor (TLR) 4 (+896 A/G) gene polymorphism has been reported to be associated with susceptibility to giant cell arteritis (GCA) with inconsistent results. To provide a more definitive conclusion, a cumulative meta-analysis of the association of TLR4 (+896 A/G) polymorphism with GCA susceptibility...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,meta分析

    doi:10.1016/j.autrev.2011.06.002

    authors: Alvarez-Rodriguez L,Muñoz Cacho P,Lopez-Hoyos M,Beares I,Mata C,Calvo-Alen J,Villa I,Martinez-Taboada VM

    更新日期:2011-10-01 00:00:00

  • T cell immunity in autoimmune hepatitis.

    abstract::T cells play a central role in the immunopathogenesis of AIH. Until recently CD4+ T cells were thought to be critical for disease development, increasing evidence has shown that CD8+ T and gammadelta T cells also play a significant role. The predisposition of certain HLA genotypes to AIH as well as the clonal expansio...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2005.01.005

    authors: Ichiki Y,Aoki CA,Bowlus CL,Shimoda S,Ishibashi H,Gershwin ME

    更新日期:2005-06-01 00:00:00

  • Treatment of rheumatoid arthritis with rituximab: an update and possible indications.

    abstract::Based on new biologic and clinical insights, the number of drugs blocking different biologic targets in rheumatoid arthritis (RA) [e.g., tumor necrosis factor alpha (TNFalpha), CTLA4, interleukin (IL)-1, IL-6, IL-15, IL-18, B lymphocyte stimulator (BLyS), CD20] has increased considerably over the last decade. Rituxima...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2006.02.007

    authors: De Vita S,Quartuccio L

    更新日期:2006-08-01 00:00:00

  • Leflunomide in psoriatic arthritis.

    abstract::Psoriatic arthritis (PsA) is a common unique form of inflammatory arthritis associated with psoriasis. Its exact prevalence is unknown but 5-30% of the 2-3% of subjects of the general population affected with psoriasis are developing PsA. Typically PsA presents as an oligoarticular asymmetrical arthritis with predomin...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2006.12.001

    authors: Kaltwasser JP

    更新日期:2007-09-01 00:00:00

  • Novel risk factors related to cancer in scleroderma.

    abstract:OBJECTIVE:Emerging data have shown an increased risk of malignancy among patients diagnosed with systemic sclerosis (SSc) so identification of risk factors linking both disorders might have prognostic implications. The aim of this study was to assess the clinical and treatment-related risk factors for cancer in a singl...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2017.03.012

    authors: Bernal-Bello D,de Tena JG,Guillén-Del Castillo A,Selva-O'Callaghan A,Callejas-Moraga EL,Marín-Sánchez AM,Fonollosa-Pla V,Simeón-Aznar CP

    更新日期:2017-05-01 00:00:00

  • The geoepidemiology of autoimmune muscle disease.

    abstract::Dermatomyositis (DM), polymyositis (PM), and sporadic inclusion-body myositis (sIBM) constitute a heterogeneous group of subacute or chronic acquired skeletal muscle diseases. Known as idiopathic inflammatory myopathies (IIM), they all share the presence of considerable weakness due to muscle inflammation and necrosis...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2009.11.006

    authors: Prieto S,Grau JM

    更新日期:2010-03-01 00:00:00

  • Intravenous immunoglobulin - indications and mechanisms in cardiovascular diseases.

    abstract::Intravenous immunoglobulin (IVIG) is efficient in various immune mediated conditions. Various cardiovascular diseases are mediated by inflammatory processes and autoimmune mechanisms. Therefore, it seems conceivable to employ IVIG as an immunomodulating therapy in such indications. In this paper we review the possible...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2008.04.001

    authors: Nussinovitch U,Shoenfeld Y

    更新日期:2008-06-01 00:00:00

  • Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15 years.

    abstract::The prevalence of ANA and anti-ENA in the general population is not well established, especially their clinical significance in healthy subjects. We herein determined the prevalence and predictive value of serum ANA and anti-ENA for connective tissue diseases (CTD), cancer, and mortality. We took advantage of a random...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2015.10.007

    authors: Selmi C,Ceribelli A,Generali E,Scirè CA,Alborghetti F,Colloredo G,Porrati L,Achenza MI,De Santis M,Cavaciocchi F,Massarotti M,Isailovic N,Paleari V,Invernizzi P,Matthias T,Zucchi A,Meroni PL

    更新日期:2016-02-01 00:00:00

  • Alpha-actinin: a multidisciplinary protein with important role in B-cell driven autoimmunity.

    abstract::Alpha-actinin (α-actinin) is a ubiquitous cytoskeletal protein, which belongs to the superfamily of filamentous actin (F-actin) crosslinking proteins. It is present in multiple subcellular regions of both muscle and non-muscle cells, including cell-cell and cell-matrix contact sites, cellular protrusions and stress fi...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2010.12.009

    authors: Oikonomou KG,Zachou K,Dalekos GN

    更新日期:2011-05-01 00:00:00

  • ITPKC susceptibility in Kawasaki syndrome as a sensitizing factor for autoimmunity and coronary arterial wall relaxation induced by thimerosal's effects on calcium signaling via IP3.

    abstract::Recently, a single nucleotide polymorphism (SNP) of the inositol 1,4,5-triphosphate kinase C (ITPKC), rs28493229, was found to passively confer susceptibility for Kawasaki syndrome (KS) and subsequent coronary arterial lesions. This association is believed to be the result of defective phosphorylation of inositol 1,4,...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2012.03.006

    authors: Yeter D,Deth R

    更新日期:2012-10-01 00:00:00

  • Mechanotransduction and epigenetic control in autoimmune diseases.

    abstract::Differentiation of epithelial cells is required to define tissue architecture and appropriate function of these cells is associated with a specific pattern of gene expression. DNA methylation, post-translational modification of histones and chromatin remodeling are nuclear mechanisms implicated in epigenetic control o...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2010.09.022

    authors: González S,Aguilera S,Urzúa U,Quest AF,Molina C,Alliende C,Hermoso M,González MJ

    更新日期:2011-01-01 00:00:00